Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-25-029044
Filing Date
2025-02-27
Accepted
2025-02-27 16:11:52
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 crdf_s-3_2.27.25.htm S-3 859392
2 EX-4.3 crdf-ex4_3.htm EX-4.3 484242
3 EX-4.4 crdf-ex4_4.htm EX-4.4 468502
4 EX-5.1 crdf-ex5_1.htm EX-5.1 76128
5 EX-23.1 crdf-ex23_1.htm EX-23.1 5119
6 EX-FILING FEES crdf-exfiling_fees.htm EX-FILING FEES 116213
7 GRAPHIC img218731228_0.jpg GRAPHIC 13714
8 GRAPHIC img218731228_1.jpg GRAPHIC 99637
9 GRAPHIC img218731228_2.jpg GRAPHIC 13714
10 GRAPHIC img218731228_3.jpg GRAPHIC 13714
11 GRAPHIC img229051243_0.jpg GRAPHIC 34763
  Complete submission text file 0000950170-25-029044.txt   2253092
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-285327 | Film No.: 25678860
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)